We develop non‑invasive assessment technology that evaluates embryo viability throughout the entire reproductive lifecycle. By analyzing biological markers without disrupting the embryo, our platform helps fertility clinics identify the most promising embryos, improving IVF success rates and reducing the need for multiple cycles.
Funding
Funding not disclosed
Founders
Product
Problem
Fertility clinics often rely on invasive embryo assessment methods that can compromise embryo integrity and provide limited predictive information, leading to lower IVF success rates and the need for multiple treatment cycles.
Solution
NoorSciences offers a non‑invasive assessment platform that evaluates biological markers of embryo viability throughout the entire reproductive lifecycle without disturbing the embryo. The technology integrates into existing IVF laboratory workflows, delivering quantitative viability scores that help clinicians select the most promising embryos for transfer. By providing actionable insights to both clinicians and patients, the platform aims to increase implantation success and reduce the number of IVF cycles required.
Target Audience
Primary customers are IVF clinics and reproductive medicine centers seeking to improve embryo selection accuracy and overall treatment outcomes.
Features
- Optical or spectroscopic imaging techniques that capture metabolic and morphological biomarkers from embryos in culture media
- Automated data analysis pipeline that generates a viability score based on validated biological markers
- Seamless integration with standard IVF incubators and laboratory information systems
- Real‑time reporting dashboard for clinicians to compare embryo viability across cohorts
- Compliance with clinical safety standards, ensuring no physical contact with embryos